Enanta Pharmaceuticals (ENTA) FCF Margin Growth (5y) (2017 - 2026)
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) FCF Margin Growth (5y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 405.22 Mn | 215.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,880.00 |
| Mar 31, 2026 | -1,840.00 |
| Dec 31, 2025 | -1,612.00 |
| Sep 30, 2025 | 1,428.00 |
| Jun 30, 2025 | 12,027.00 |
| Mar 31, 2025 | -15,922.00 |
| Dec 31, 2024 | -17,322.00 |
| Sep 30, 2024 | -14,855.00 |
| Jun 30, 2024 | -11,743.00 |
| Mar 31, 2024 | -25,138.00 |
| Dec 31, 2023 | -18,460.00 |
| Sep 30, 2023 | -16,257.00 |
| Jun 30, 2023 | -18,659.00 |
| Mar 31, 2023 | -7,193.00 |
| Dec 31, 2022 | -17,475.00 |
| Sep 30, 2022 | -15,870.00 |
| Jun 30, 2022 | -7,954.00 |
| Mar 31, 2022 | -10,136.00 |
| Dec 31, 2021 | -7,036.00 |
| Sep 30, 2021 | -6,952.00 |